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Abstract
Transdifferentiation is a complete and stable change in cell identity that serves as an alternative to 
stem-cell-mediated organ regeneration. In adult mammals, findings of transdifferentiation have 
been limited to the replenishment of cells lost from preexisting structures, i.e., in the presence of a 
fully developed scaffold and niche1. Here we show that transdifferentiation of hepatocytes in the 
liver can build a structure that failed to form in development—the biliary system in mice that 
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mimic the hepatic phenotype of human Alagille syndrome (ALGS)2. In these mice, hepatocytes 
convert into mature cholangiocytes and form bile ducts that are effective in draining bile and 
persist after the cholestatic liver injury is reversed, consistent with transdifferentiation. These 
findings redefine hepatocyte plasticity, which appeared to be limited to metaplasia, i.e., incomplete 
and transient biliary differentiation as an adaptation to cell injury, based on previous studies in 
mice with a fully developed biliary system3–6. We show that, in contrast to bile duct 
development7–9, de novo bile duct formation by hepatocyte transdifferentiation is independent of 
NOTCH signaling. We identify TGFβ signaling as the driver of this compensatory mechanism and 
show that it is active in some patients with ALGS. We also show that TGFβ signaling can be 
targeted to enhance the formation of the biliary system from hepatocytes, and that the 
transdifferentiation-inducing signals and remodeling capacity of the bile-duct-deficient liver can 
be harnessed with transplanted hepatocytes. Our results define the regenerative potential of 
mammalian transdifferentiation and reveal opportunities for therapy of ALGS and other 
cholestatic liver diseases.
In regenerating organs of adult mammals, differentiated cells can replenish other types of 
differentiated cells by transdifferentiation, as in the pancreatic islet10, gastric gland11, lung 
alveolus12 and intestinal crypt13. Whether mammalian transdifferentiation can build these or 
other structures de novo is unknown. In the liver, hepatocytes can undergo biliary 
differentiation to form reactive ductules both in humans14–17 and animals with cholestatic 
liver injury3–6,18–21. However, hepatocyte-derived biliary cells exhibit incomplete biliary 
and residual hepatocyte differentiation, i.e., are not mature cholangiocytes, and revert back 
to their original identity after the injury is reversed3–6. Moreover, hepatocyte-derived 
ductules do not contribute to bile drainage5. These findings are consistent with metaplasia, 
but not transdifferentiation, and call into question the functional significance of hepatocyte 
plasticity. However, all studies of hepatocyte plasticity published to date used animals with a 
fully developed biliary system in which residual cholangiocytes are available to regenerate 
injured bile ducts, likely leading to insufficient pressure for transdifferentiation. To 
determine the full extent of hepatocyte plasticity, we used mice lacking the intrahepatic 
biliary system.
Specifically, we used mice that mimic the hepatic phenotype of ALGS—a human disease 
caused by impaired NOTCH signaling22–24—generated by deletion of floxed alleles of the 
NOTCH signaling effector RBPJ and, to prevent compensation25, the transcription factor 
HNF6 (also known as ONECUT1) in embryonic liver progenitors using Cre expressed from 
an albumin promoter (Alb)2. These Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice are severely cholestatic 
because they lack peripheral bile ducts (pBDs), the branches of the intrahepatic biliary tree, 
at birth; however, >90% of the mice survive and form pBDs and a functional biliary tree by 
postnatal day (P) 12026 (Fig. 1a). Although Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice have hilar bile 
ducts (hBDs), the trunk of the biliary tree, we hypothesized that the new pBDs originate 
from hepatocytes because the livers of Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice contain hybrid cells 
expressing hepatocyte and biliary markers2,26. To test this hypothesis, we developed Cre-
independent hepatocyte fate tracing. For this, we activated the Flp-reporter GFP gene in 
R26ZG+/+ mice specifically in hepatocytes by intravenous injection of an adeno-associated 
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virus (AAV) serotype 8 vector expressing Flp from the transthyretin (Ttr) promoter (Fig. 1a 
and Extended Data Fig. 1a–g).
To trace hepatocytes during pBD formation, we intravenously injected Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice with AAV8-Ttr-Flp at P17, i.e., before cells expressing 
biliary markers emerge in the liver periphery2,26. At P120, the newly formed pBDs—
identified by wsCK IF—were GFP positive, indicating hepatocyte origin (Fig. 1a, b). In 
contrast, pBDs that formed normally during liver development in Cre-negative littermates 
were GFP negative (Extended Data Fig. 2a, b). In many pBDs of Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice all cells were GFP positive, while the overall labeling 
efficiency of peripheral cholangiocytes was 39.2 ± 7.2% (mean ± SEM); however, this 
number correlated well with the hepatocyte labeling efficiency (36.6 ± 4.8%; paired 2-sided 
Student’s t-test; P=0.48) (Extended Data Fig. 2c), indicating that all peripheral 
cholangiocytes originated from hepatocytes. We also observed hepatocyte-derived peripheral 
cholangiocytes in mice in which hepatocytes were labeled after weaning (P39) (Extended 
Data Fig. 2d, e). These results show that hepatocytes can form pBDs de novo.
To investigate the function of the hepatocyte-derived pBDs (HpBDs), we determined if they 
are contiguous with the extrahepatic biliary system. At P30, retrograde ink injection into the 
common bile duct filled only hBDs, reflecting a severely truncated biliary tree lacking 
pBDs; however, ink injection at ≥P120 revealed a biliary tree of normal dimensions, 
demonstrating that HpBDs are connected to and patent with hBDs (Fig. 1c). 3D 
reconstruction of confocal imaging confirmed that HpBDs form contiguous lumens with 
DBA-labeled hBDs (Fig. 1d and Supplementary Video 1). Accordingly, HpBDs were 
effective in draining bile, as evidenced by normalization of serum markers of cholestasis 
(total bilirubin and ALP; Extended Data Fig. 3a–c) and hepatocyte injury (ALT and AST; 
Extended Data Fig. 3d, e) and resolution of cholestasis-induced liver fibrosis (Sirius-red 
staining; Extended Data Fig. 3f). A few mice that continued to have elevated serum total 
bilirubin and liver fibrosis showed abundant wsCK-positive hepatocytes but no HpBDs 
(Extended Data Fig. 3a, b, g). In contrast to the transient hepatocyte-derived ductules 
observed in other mouse models of cholestatic liver injury3–6, HpBDs were stable beyond 
the time when cholestasis and liver injury were resolved and were maintained for life 
(≥P334) (Fig. 1c, e). These results show that HpBDs provide normal and stable biliary 
function.
We also investigated the authenticity and maturity of the cholangiocytes forming the 
HpBDs. The cells displayed acetylated tubulin (acTUB)-marked primary cilia (Fig. 2a), 
indicating a switch from hepatocyte to biliary fate19, and somatostatin receptor 2 (SSTR2) 
(Fig. 2b), a marker of biliary function27. They also expressed the mature biliary markers 
EPCAM and CK19 (Fig. 2c), which are lacking or expressed at low levels in hepatocyte-
derived metaplastic biliary cells3,5. To substantiate these results, we performed RNA 
sequencing (RNA-seq) on hepatocyte-derived peripheral cholangiocytes isolated as 
EPCAM-positive DBA-negative cells by FACS from >P115 Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice 
(Extended Data Fig. 4a). Rbpj and Hnf6 were deleted in these cells (Extended Data Fig. 4b, 
c), which was expected because Alb-Cre is active in embryonic liver progenitors before they 
commit to hepatocyte or biliary fate2,9. Principal-component analysis showed that 
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hepatocyte-derived peripheral cholangiocytes cluster closely with normal peripheral 
cholangiocytes isolated from Cre-negative littermates, but not with parental hepatocytes 
(Fig. 2d, e and Supplementary Table 1). Accordingly, hepatocyte-derived peripheral 
cholangiocytes expressed normal levels of mature biliary markers that are virtually 
undetectable in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet-induced hepatocyte-
derived metaplastic biliary cells3, except for CFTR, which is less enriched in cholangiocytes 
than the other markers (Fig. 2f). Hepatocyte-derived peripheral cholangiocytes also 
expressed other commonly used markers of biliary differentiation3,5,20,25,27,28 at normal or 
near-normal levels (Fig. 2f), and showed virtually no memory of hepatocyte 
differentiation3,29,30 (Fig. 2g and Extended Data Fig. 4d). These results show that 
hepatocyte-derived peripheral cholangiocytes are authentic and mature peripheral 
cholangiocytes.
Next, we investigated the contribution of proliferation to HpBD formation, i.e., whether a 
few hepatocytes proliferate extensively after transdifferentiation, or whether many 
hepatocytes transdifferentiate. For this, we measured clonal expansion in HpBDs by sparsely 
labeling hepatocytes in Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice with low-dose AAV8-Ttr-
Flp at P18 and quantifying the cells in GFP-positive clones at P120 (Fig. 3a). Surprisingly, 
we found only 1.56 ± 0.05 cells/clone in HpBDs, with 1-cell clones accounting for 63.8 
± 3.6% of clones. To exclude that the nonintegrating AAV vector missed proliferating 
hepatocytes, we analyzed clone size in Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− mice in 
which hepatocytes and hilar cholangiocytes are stochastically labeled with 1 of 4 fluorescent 
proteins (Fig. 3b and Supplementary Video 2). We found 1.91 ± 0.06 cells/clone and 45.6 
± 1.1% 1-cell clones in HpBDs at P150. In addition, the number of cells per clone in hBDs 
was similar between these mice and Alb-Cre+/−;R26R-Confetti+/− control mice at P90 (2.08 
± 0.08 and 2.41 ± 0.01; 2-sided Student’s t-test; P=0.060) (Extended Data Fig. 5a). These 
results show that HpBDs are polyclonal, i.e., form with little proliferation, and confirm that 
hilar cholangiocytes do not contribute to HpBD formation.
Unlike in HpBDs, we found significant proliferation in hepatocyte-derived reactive ductules, 
which are detectable in Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice during cholestasis 
(Extended Data Fig. 5b). Clonal analysis showed 2.70 ± 0.08 cells/clone in reactive ductules 
in P90 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− mice, with more 3- and 4-cell clones 
than in pBDs in Alb-Cre+/−;R26R-Confetti+/− mice (Extended Data Fig. 5c). Because 
HpBDs form with little proliferation, we reasoned that these proliferating cells are 
hepatocyte-derived metaplastic biliary cells3–6. Indeed, we found that 93.51 ± 0.81% of the 
proliferating biliary cells identified by KI67 and osteopontin (OPN) IF in Alb-Cre
+/−;Rbpjf/f;Hnf6f/f mice near the peak of cholestasis (P54) were CK19 negative (Extended 
Data Fig. 5d).
We also investigated proliferation in established HpBDs by inducing cholestatic liver injury 
with DDC diet in >P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice. Reactive ductules formed 2 weeks 
later than in Cre-negative littermates and consisted mainly of OPN-positive EPCAM-
negative cells, indicative of hepatocyte metaplasia (Extended Data Fig. 5e). Indeed, after 
feeding DDC diet to Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice in which hepatocyte fate 
tracing was induced at >P120, we found that 84.5 ± 5.6% of the cells in reactive ductules 
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originated from hepatocytes, in contrast to 20.1 ± 3.0% in Cre-negative littermates 
(Extended Data Fig. 5f). These results confirm that NOTCH signaling is important for 
cholangiocyte proliferation31, which explains our finding of a limited role of proliferation in 
HpBD formation and underscores the authenticity of hepatocyte-derived peripheral 
cholangiocytes.
As illustrated by lack of pBDs in Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice (Fig. 1c), NOTCH 
signaling is needed for bile duct development7–9, raising the question of which signaling 
pathway drives HpBD formation in its absence (Extended Data Fig. 4b, c). We focused on 
TGFβ signaling because it promotes biliary differentiation and morphogenesis in 
development32, although it is not essential, as shown by development of a normal biliary tree 
in mice lacking the TGFβ type II receptor (TGFBR2) in embryonic liver progenitors 
(Extended Data Fig. 6a). We reasoned that TGFβ signaling is induced in hepatocytes of Alb-
Cre+/−;Rbpjf/f;Hnf6f/f mice because of the paradoxical role of HNF6 in liver development—
it activates the biliary transcription factors HNF1β and SOX925,33, but inhibits 
TGFBR232,34. Indeed, gene ontology (GO) term enrichment analysis of our RNA-seq data 
suggested active TGFβ signaling in hepatocyte-derived peripheral cholangiocytes, but not in 
normal peripheral cholangiocytes (Supplementary Table 1, Down pC vs. HpC). Moreover, 
we found high levels of phosphorylated SMAD3 (pSMAD3) in nuclei of periportal HNF1-
positive epithelial liver cells and in whole-liver nuclear extracts in Alb-Cre+/−;Rbpjf/f;Hnf6f/f 
mice at P60 (Extended Data Fig. 6b, c).
We functionally validated these findings by showing that the TGFβ inhibitor SB-431542 
blocks biliary differentiation and morphogenesis of hepatocytes lacking RBPJ and HNF6 in 
vitro (Extended Data Fig. 6d–f). Moreover, at >P120, HpBDs were still absent or severely 
truncated, and liver fibrosis persisted, in 14/16 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f mice 
that, like Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice, were cholestatic at P34–53 (Fig. 3c, d and 
Extended Data Fig. 6c, g).
These findings led us to investigate whether activating TGFβ signaling in hepatocytes 
enhances HpBD formation. We intravenously injected P19–24 Alb-Cre+/−;Rbpjf/f;Hnf6f/f 
mice with an AAV8 vector expressing constitutively active (ca) TGFBR1 from the 
elongation factor 1α (Ef1α) promoter. At P80–100, 9/11 treated mice had a mature 
hierarchical biliary network, whereas 9/9 untreated mice still had an immature homogeneous 
biliary network35 (Fig. 3e). Reflecting improved bile drainage, cholestasis and liver fibrosis 
resolved faster in treated mice (Fig. 3f, g). We excluded that AAV8-Ef1α-caTgfbr1 is 
fibrogenic in Rbpjf/f;Hnf6f/f mice (Extended Data Fig. 6h). These results identify TGFβ 
signaling as the driver of transdifferentiation and morphogenesis in HpBD formation.
To exclude that transdifferentiation is limited to immature hepatocytes, we investigated 
whether adult hepatocytes can form HpBDs. To bypass potential adaptive processes in 
development, we deleted Rbpj and Hnf6 and activated GFP in hepatocytes of P75 
Rbpjf/f;Hnf6f/f;R26ZG+/+ mice by co-injecting AAV8-Ttr-Cre and AAV8-Ttr-Flp and 
transplanted the cells 1 week later into P31 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Rag2−/−;Il2rg−/− mice 
(Fig. 4a). After P120, we found donor hepatocyte-derived mature peripheral cholangiocytes 
in 5.2 ± 0.8% of the portal areas containing donor cells (Fig. 4b). We also transplanted 
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NOTCH signaling-competent wildtype hepatocytes, which produced donor-derived HpBDs 
in 78.3 ± 13.9% of such portal areas because 31.6 ± 7.9% of the transplanted cells 
proliferated after transdifferentiation into cholangiocytes (Fig. 4a, c, d). These results show 
that adult hepatocytes, and transplanted hepatocytes, respond to the transdifferentiation-
inducing and morphogenetic signals in the bile-duct-deficient liver and form HpBDs.
To determine whether our findings are relevant for human ALGS, we obtained liver samples 
from 2 patients who developed regenerative nodules containing pBDs36 (Extended Data 
Table 1). The regenerative nodules contained CK7-positive pBDs, whereas nonregenerated 
liver tissue from the same patients showed abundant CK7-positive cells with hepatocyte 
morphology, indicative of metaplasia14–17 (Fig. 4e). To determine if TGFβ signaling is 
active in the new pBDs, we used pSMAD3 IF. We found nuclear localization of pSMAD3 in 
56.1 ± 6.1% of the pBDs in regenerative nodules, but not in pBDs in normal human liver 
(Fig. 4f). These results suggest that the TGFβ-mediated mechanism of HpBD formation 
identified in Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice is also active in some patients with ALGS.
In conclusion, by showing that hepatocytes can convert into mature cholangiocytes and form 
a functional and stable biliary system, our findings establish that hepatocyte plasticity 
extends beyond metaplasia to transdifferentiation and provide the first example of 
mammalian transdifferentiation building an organ structure de novo. Although hilar 
cholangiocytes are present in our mice, they fail to expand, resulting in severe cholestatic 
liver injury and strong pressure for hepatocytes to transdifferentiate into peripheral 
cholangiocytes. Analogously, cholangiocytes transdifferentiate into hepatocytes only if 
hepatocyte proliferation is completely suppressed37. The failure of hilar cholangiocytes to 
proliferate is likely caused by high TGFβ signaling in the cholestatic liver38. Accordingly, 
we identified TGFβ signaling as the driver of hepatocyte transdifferentiation and HpBD 
formation in our mice and potentially also in patients with ALGS. Unlike for bile duct 
development7–9, NOTCH signaling is not needed. Using clinically established AAV vectors 
and hepatocyte transplantation we show that our findings are potentially translatable into 
therapies for ALGS and other diseases associated with lack of bile ducts.
Methods
Mice.
Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice (mixed background) were previously reported2,26. R26R-
RFP+/+39 (C57BL/6) and R26NZG+/+40 (FVB) mice were used. Flp-reporter mice were 
generated by crossing R26NZG+/+ mice with EIIa-Cre+/+41 mice (C57BL/6) to remove the 
Cre-reporter element and then crossing out the EIIa-Cre. These R26ZG+/+ mice were 
crossed with Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice to generate Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG
+/+
 mice. R26R-Confetti+/+42 mice (C57BL/6) were crossed with Alb-Cre+/−;Rbpjf/f;Hnf6f/f 
mice to generate Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− mice. Tgfbr2f/f43 mice 
(C57BL/6) were crossed with Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice to generate Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f mice. Because Tgfbr2 (68.39 cM) and Hnf6 (41.93 cM) are both 
on chromosome 9, recombinants were generated at 0.1356 (35/258 mice) observed 
frequency (0.26 expected frequency). Different founder recombinants were intercrossed to 
generate Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f mice. R26R-ZsGreen+/+44 mice (C57BL/6) 
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were crossed with Alb-Cre+/− mice to generate Alb-Cre+/−;R26R-ZsGreen+/+ mice. Alb-Cre
+/−;Rbpjf/f;Hnf6f/f mice were crossed with Rag2−/−45;Il2rg−/−46 mice (mixed background) to 
generate Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Rag2−/−;Il2rg−/− mice. Male and female mice of the 
indicated age and genotype were chosen randomly for inclusion in experiments. The mouse 
used as a positive control for biliary gene expression was a C57BL/6 wildtype mouse fed 
choline-deficient diet (MP Biomedicals) and given 0.15% (w/v) ethionine (Sigma-Aldrich) 
in the drinking water (CDE diet) for 3 weeks. All mice were kept under barrier conditions. 
All procedures were approved by the Institutional Animal Care and Use Committee at UCSF 
or CCHMC.
Adeno-associated virus.
The AAV-Ttr-Flp plasmid was generated by removing Cre from AAV-Ttr-Cre47 and 
replacing it with Flpo48 from pPGKFlpobpA (Addgene 13793); viruses were produced by 
Vector Biolabs and used at a high dose of 1–3 × 1012 vgs or low dose of 4 × 1011 vgs. The 
AAV-Ef1α-caTgfbr1 plasmid was built by VectorBuilder to contain the activating T204D49 
mutation; virus was produced by Vector Biolabs and used at a dose of 1 × 1011 vgs. Titers 
were determined using qPCR. Viruses were delivered by tail vein injection in volumes ≤100 
μL to prevent hydrodynamic effects.
Tissue collection.
Livers from Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+, R26R-Confetti+/− and transplanted mice 
were perfused with ice-cold PBS followed by 4% paraformaldehyde (PFA). Samples were 
cut into slices and fixed overnight in 4% PFA at 4°C. Livers from R26R-RFP+/+, Alb-Cre
+/−;Rbpjf/f;Hnf6f/f, Rbpjf/f;Hnf6f/f and Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice were fixed 
overnight in 4% PFA at 4°C. For thin sectioning, samples were moved to 30% sucrose 
overnight at 4°C to cryopreserve and then embedded in OCT (Tissue-Tek) or processed for 
paraffin embedding and sectioning. A Leica CM3050 S cryostat was used to cut 6 μm 
cryosections for staining and imaging. For 3D and sparse-labeling clonal analysis, liver 
samples were embedded in 4% agarose and sectioned on a Leica VT100 S vibratome. For 
clonal analysis in R26R-Confetti+/− mice, liver samples were cut into 1 mm slivers, 
immunostained, washed in PBS, equilibrated in 30% sucrose and embedded in OCT. The 1 
mm slivers were then cryosectioned at 100 μm, stained with Hoechst and mounted in PBS 
for confocal imaging. For analysis of Flp-based hepatocyte fate tracing in R26ZG+/+ mice, 
liver samples were fixed in neutral-buffered formalin containing zinc (Z-Fix, Anatech), 
embedded in paraffin and sectioned to 5 μm.
Human liver tissue.
Explant samples from the regenerative nodule and nonregenerated liver tissue of a 3-year-old 
male patient with ALGS were previously described; regenerative nodule and nonregenerated 
liver tissue contained the same heterozygous JAG1 exon 1–26 deletion36. Samples were 
obtained with patient consent and approval from the Commission Cantonale d’Ethique de la 
Recherché CCER. Biopsy samples from the regenerative nodule and nonregenerated liver 
tissue of a 15-year-old male patient with ALGS caused by a heterozygous c.499T>A 
(p.W167R) JAG1 mutation and resection samples from a histologically normal region of the 
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liver of a 35-year-old male undergoing surgery for metastasis of rectal adenocarcinoma were 
obtained with patient consent and approval from the UCSF Institutional Review Board.
Immunostaining and histology.
Cryosections were blocked in 10% normal serum and permeabilized in 0.3% Triton-X 
before staining with primary and secondary antibodies listed in Supplementary Tables 2 and 
3. Paraffin-embedded samples were deparaffinized and underwent antigen retrieval in 
sodium citrate buffer (Bio-Genex or Vector Labs) or Tris EDTA buffer (10mM Tris Base, 
1mM EDTA, 0.05% Tween 20, pH 9.0) in a steamer or pressure cooker for 15 minutes 
before blocking and permeabilization. Thin sections were mounted in FluorSave 
(MilliporeSigma) or 50% glycerol. Vibratome sections were stained free-floating in 12-well 
dishes and cleared in Focus Clear (Cedarlane Laboratories) before being mounted in Mount 
Clear (Cedarlane Laboratories) for confocal imaging. All samples stained with anti-wsCK 
antibody underwent antigen retrieval in 100 mM Tris buffer (pH 9.5) at 55°C for 2 hours 
before blocking. Staining with anti-pSMAD3 antibody used a biotinylated secondary 
antibody followed by avidin/biotin-based peroxidase and tyramide amplification. Staining 
with anti-SSTR2 antibody used an HRP secondary antibody followed by tyramide-based 
amplification. M.O.M. Kit (Vector Laboratories) was used for antibodies raised in mice. 
DAPI or Hoechst was used to stain nuclear DNA. Chromogenic detection used an HRP 
secondary antibody followed by avidin/biotin-based peroxidase amplification and DAB 
substrate exposure. Sirius-red staining was performed on deparaffinized and rehydrated 
samples using a 0.1% Picrosirius-red solution (Dudley Corporation and Newcomer Supply) 
and 0.5% acetic acid water washes or was done at Peninsula Histopathology Laboratory.
Imaging.
Thin sections were imaged on an Olympus BX51 upright microscope and cultured cells 
were imaged on an Olympus IX71 inverted microscope using Openlab software 
(PerkinElmer). Chromogenic stains were imaged on a Leica DM 1000 LED. Fiji50 and/or 
Photoshop (Adobe) were used to process (brightness, contrast and gamma) and merge 
channels. Thick sections for 3D analysis of connectivity and clonal analysis were imaged on 
a Leica upright AOBS confocal microscope and processed and analyzed using Imaris 
(Bitplane) or Volocity (PerkinElmer) software. For R26R-Confetti+/− mouse and pSMAD3 
analysis, images were acquired using a Nikon A1R GaAsP inverted SP confocal microscope 
and NIS elements software and processed and analyzed using Imaris software. Sirius-red-
stained sections were imaged using a Cytation 5 cell imaging multi-mode reader (BioTek).
Ink injection.
A catheter was inserted in a retrograde fashion into the common bile duct of postmortem 
mice and waterproof ink (Higgins) was slowly injected. Left liver lobes were dehydrated in 
1:1 methanol:water followed by 100% methanol. Ink was visualized by tissue clearing in 1:2 
benzyl alcohol:benzyl benzoate (BABB) solution and imaged on a Leica M205A or Nikon 
SMZ800 stereoscope.
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Cholangiocyte isolation.
Nonparenchymal liver cells were isolated from >P115 Alb-Cre+/−;Rbpjf/f;Hnf6f/f and 
Rbpjf/f;Hnf6f/f mice as previously described51. Cells were resuspended at 1 × 107 cells/mL 
in DMEM/2% FBS and blocked with Mouse Fc Block (BD Biosciences) for 30 minutes. 
Cells were incubated with fluorochrome-conjugated antibodies (Supplementary Table 2) and 
DBA-FITC (Vector Laboratories) for 30 minutes, washed with cold DPBS 3 times and 
resuspended in DMEM/2% FBS. Sytox Red (Thermo Fisher Scientific) was added to label 
dead cells prior to sorting. Unstained and single-stained cells were used for compensation. 
Specificity of DBA binding was verified with a GalNAc (Sigma)-blocked control as 
previously described52. Cells were analyzed and sorted on a FACSAria III using FACSDiva 
software (BD Biosciences). From the CD11b–CD31–CD45– population, EPCAM+DBA– 
cells were collected as peripheral cholangiocytes and EPCAM+DBA+ as hilar 
cholangiocytes. FlowJo (FlowJo, LLC) was used to analyze data and generate charts. Cells 
were either sorted into DMEM/2% FBS, pelleted and snap frozen, or sorted directly into 
extraction buffer for RNA purification.
Hepatocyte isolation.
Hepatocytes were isolated from >P115 Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice by 2-step 
collagenase (Worthington) perfusion followed by purification through a Percoll gradient. 
Cells were resuspended at 1 × 106 cells/100 μL in Hanks Buffer with 10% FBS and 
incubated with OC2–2F8 antibody (Supplementary Table 2) for 1 hour on ice. Cells were 
washed with cold DPBS 2 times and resuspended in Hanks/10% FBS. Fluorochrome-
conjugated secondary antibody (Supplementary Table 3) was added and cells were incubated 
for 30 minutes on ice followed by 2 washes with cold DPBS. Cells were blocked with 5% 
normal rat serum (Jackson Immuno) in Hanks Buffer for 10 minutes on ice. Cells were then 
incubated with fluorochrome-conjugated antibodies (Supplementary Table 2) for 30 minutes 
on ice. Cells were then washed in cold DPBS 3 times and resuspended in Williams E 
medium/2% FBS. Sytox Red (Thermo Fisher Scientific) was added to label dead cells prior 
to sorting. Unstained and single-stained cells were used for compensation. Cells were 
analyzed and sorted on a FACSAria III using FACSDiva software (BD Biosciences). From 
the CD11b–CD31–CD45–EPCAM– population, OC2–2F8+ cells were collected as 
hepatocytes (Supplementary Fig. 2). Cells were either sorted into DMEM/2% FBS, pelleted 
and snap frozen, or sorted directly into extraction buffer for RNA purification.
Hepatocyte transplantation.
Hepatocytes were isolated from donor mice by 2-step collagenase perfusion followed by 
purification through a Percoll gradient. 1 × 106 viable cells were resuspended in 80–100 μl 
of Williams E Medium with glutamine. Transplantation was performed by transdermal 
intrasplenic injection of the cell suspension under isoflurane anesthesia.
DDC diet feeding.
Mice received PicoLab Mouse Diet 20, 5058 (LabDiet) with 0.1% 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC; Sigma-Aldrich) for the indicated durations.
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qPCR and gene expression analysis.
Genomic DNA was isolated from cells using QIAamp DNA Micro Kit or DNeasy Blood & 
Tissue Kit (Qiagen). RNA was extracted using Trizol Reagent (Thermo Fisher Scientific) 
and purified by isopropanol precipitation (cells in collagen gel) or purified using RNAeasy 
Mini Kit (Qiagen) (liver tissue). Reverse transcription was performed using qScript cDNA 
Supermix (Quanta Biosciences). qPCR was performed using SYBR green reagent (Thermo 
Fisher Scientific) in a ViiA 7 system (Thermo Fisher Scientific). Reactions were performed 
in triplicate, and expression was normalized to an Rbpj (genotyping) or Gapdh (gene 
expression) reference and quantified using the ΔΔCt method. Primers are listed in 
Supplementary Table 4.
RNA-seq.
RNA was purified from FACS-isolated cells using PicoPure Kit (Thermo Fisher Scientific). 
RNA quality was assessed using RNA 6000 Pico Kit on a 2100 Bioanalyzer (Agilent). 
Samples with RIN ≥ 7.7 and at least 15 ng of RNA were used to construct sequencing 
libraries using Clontech Low Input Library Prep Kit v2. Libraries were sequenced on a 
HiSeq 3000, 10 samples per lane, with single-end 50 bp reads. Raw reads were aligned to 
the mm10 mouse genome with annotations provided by UCSC using CobWEB, a 
proprietary Burrows-Wheeler Transform method. Reads per kb per million (RPKM) were 
calculated from aligned reads using the expectation-maximization algorithm. RPKM was 
thresholded at 1, log2 transformed, normalized using the DESeq algorithm and baselined to 
the median of all samples. Analyses were performed on transcripts with RPKM > 5 in all 
samples of at least 1 experimental condition (n=17,793 transcripts). These reasonably 
expressed transcripts were used in principle-component analysis. All transcripts with fold 
change > 3 in at least 1 of the 3 possible pairwise comparisons (n=6,464) were selected, and 
a 1-way ANOVA was performed to identify significantly differential genes with FDR-
corrected P<0.05 (n=4,997). Venn diagrams were used to identify unique and shared gene 
signatures. Gene sets were submitted to ToppGene.cchmc.org for identification of pathway 
and biological process enrichments.
Western blot.
Nuclear and cytoplasmic extracts were generated from whole liver using previously 
described buffers with protease and phosphatase inhibitors53. Samples were run on SDS-
PAGE 4–20% Tris-Glycine gradient gels, electrophoretically transferred to nitrocellulose 
membrane and probed with antibodies. Signals were detected by ECL Western blotting 
substrate (GE Healthcare). The membrane was stripped and reprobed with anti-actin 
antibody to verify and normalize protein loading using densitometry. Quantification was 
performed using ImageJ software.
Serum chemistry.
Blood was collected from postmortem Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice and controls of ages 
P20 to ≥P150 and tested for serum total bilirubin (TecoDiagnostics) and ALP, ALT and AST 
(ADVIA XPT clinical chemistry system, Siemens). For serial bilirubin measurements, blood 
was collected by retro-orbital venipuncture and tested for total bilirubin every 2 weeks from 
Schaub et al. Page 10
Nature. Author manuscript; available in PMC 2019 June 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
P60 to P189 from 4 different litters. Blood was collected from Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f mice and controls by retro-orbital venipuncture and tested for 
serum total bilirubin (TecoDiagnostics). Blood was collected from Alb-Cre
+/−;Rbpjf/f;Hnf6f/f mice intravenously injected with AAV8-Ef1α-caTgfbr1 and controls by 
retro-orbital venipuncture and serum total bilirubin was measured as previously reported54 
using a Synergy 2 microplate reader (BioTek). Serum absorbance at 540 nm was subtracted 
from serum absorbance at 450 nm. A linear trendline equation of serum absorbance vs. 
serum total bilirubin was determined by independently measuring absorbance and total 
bilirubin (TecoDiagnostics) of known cholestatic and noncholestatic serum samples. This 
equation was used to convert absorbance readings to serum total bilirubin levels.
In vitro conversion assay.
In vitro 3D culture of hepatocytes to induce biliary conversion was carried out as previously 
reported21 with the following modifications. Hepatocytes were isolated from 8–10-week-old 
Rbpjf/f;Hnf6f/f mice injected with 1 × 1012 vgs of AAV8-Ttr-Cre 2 weeks prior to delete 
Rbpj and Hnf6. Hepatocytes were isolated by 2-step collagenase perfusion followed by 
purification through a Percoll gradient, all in the absence of serum. Cells were grown on 
Primaria plates for 6 days to form spheroids. Spheroids were cultured in collagen gels 
(Cultrex Rat Collagen I, Lower Viscosity, Trevigen) in the presence of 10 μM SB-431542 
(Selleckchem) or vehicle (DMSO). The medium was changed every other day.
Quantification and statistics.
For sparse-labeling clonal analysis, 8 liver regions from each of 3 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice were analyzed. GFP-positive cells in all clones within 
100 μm-thick sections were manually counted using Imaris software for visualization. GFP-
positive cells in direct contact were considered clones. Clones that extended to and 
potentially beyond the x, y or z boundaries were excluded. For clonal analysis in R26R-
Confetti+/− mice, 30–40 μm z-stack images of wsCK-positive DBA-negative pBDs and 
wsCK-positive DBA-positive hBDs were visualized in 3D with Imaris software. The module 
Surfaces within Imaris was used to render a 3D surface created on an intensity value on a per 
channel basis. The rendered surface-per-channel was masked to the Hoechst nuclear stain. 
3D pBD masks were used to manually count cells per clone. Multiple portal regions were 
analyzed for clones at P90 (14 and 17 per Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− and 8 
and 9 per Alb-Cre+/−;R26R-Confetti+/− mouse) and P150 (7–10 per Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− and 8–10 per Alb-Cre+/−;R26R-Confetti+/− mouse). To 
determine labeling efficiencies in Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice, for each 
mouse, 20 random fields were analyzed for wsCK-positive DBA-negative peripheral 
cholangiocytes (~350 cells) and 5 random fields were analyzed for hepatocytes (~1,500 
cells). For proliferation analysis, OPN-positive cells in 4 random portal fields from each of 4 
mice were analyzed for KI67 and CK19 staining. For hepatocyte-fate-tracing analysis in 
DDC diet-fed mice, 10 random portal fields from 4 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ 
and 3 Rbpjf/f;Hnf6f/f;R26ZG+/+ mice were analyzed. For quantification in transplantation 
experiments, all portal areas with donor-derived cells in a section from at least 3 lobes per 
mouse were examined and scored for the presence or absence of donor hepatocyte-derived 
EPCAM-positive cholangiocytes. For human samples, 63 bile ducts between the 2 patient 
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samples and 45 bile ducts in the control sample were scored for the presence of nuclear 
pSMAD3. For Sirius-red-staining quantification, liver samples were stained in batches and 
sections of whole lobes were imaged at equal exposure. Using Fiji software, a threshold was 
set for Sirius-red-positive area within each lobe and the percent of the total area that was 
Sirius red positive was measured and is reported. Charts were generated in Prism 6 or 7 
(GraphPad). Researchers were not blinded when analyzing results. P<0.05 was considered 
statistically significant. Experiments were replicated independently once (Fig. 2a, b, d–g; 
Fig. 3a, b, d, g; Extended Data Fig. 1c–g; Extended Data Fig. 2c, e; Extended Data Fig. 3a–
g; Extended Data Fig. 4b–d; Extended Data Fig. 5a, c, d, f; Extended Data Fig. 6c, g; 
Supplementary Table 1), at least twice (Fig. 1d, e; Fig. 2c; Fig. 3f; Fig. 4b–f; Extended Data 
Fig. 5b, e; Extended Data Fig. 6a, b, e, f, h; Supplementary Video 1) or at least thrice (Fig. 
1b, c; Fig. 3c, e; Extended Data Fig. 2b; Extended Data Fig. 4a; Supplementary Video 2). 
No statistical methods were used to predetermine sample size.
Data availability.
The Gene Expression Omnibus accession number for the RNA-seq data is GSE108315. 
Additional data are available from the corresponding authors on reasonable request.
Extended Data
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Extended Data Figure 1: Flp-based hepatocyte fate tracing.
a, R26ZG allele. b, Experimental design for establishing efficient, specific and constitutive 
labeling of hepatocytes in normal adult R26ZG+/+ mice. c-f, IF of R26ZG+/+ mouse liver 
(n=2) for GFP and the hepatocyte marker major urinary protein (MUP) (c), peripheral and 
hilar cholangiocyte marker CK19 (d, e), hilar-cholangiocyte-specific marker DBA (e), 
hepatic stellate cell marker desmin (DES), macrophage marker F4/80 and endothelial cell 
marker LYVE1 (f) 2 weeks (wks) after intravenous injection of 1 × 1012 viral genomes (vgs) 
of AAV8-Ttr-Flp. g, Reporter activation in R26ZG+/+ mice 1 and 2 weeks after intravenous 
injection of the indicated dose of AAV8-Ttr-Flp (n=1 for each dose and time point). Scale 
bars, 100 μm.
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Extended Data Figure 2: Efficiency of hepatocyte fate tracing in mice born with or without 
pBDs.
a, b, Experimental design for hepatocyte fate tracing at P17 and IF at P120 in 
Rbpjf/f;Hnf6f/f;R26ZG+/+ mice (n=4). c, Correlation of GFP labeling efficiency between 
hepatocytes and peripheral cholangiocytes in hepatocyte-fate-traced P120 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice (n=5, top and bottom). Measure of center is mean. d, e, 
Experimental design for hepatocyte fate tracing at P39 and IF at P120 in Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice (n=3). Scale bars, 100 μm.
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Extended Data Figure 3: HpBDs relieve cholestasis and liver injury.
a, Serum total bilirubin levels in P20–29 (n=6), P30–39 (n=33), P40–49 (n=35), P50–59 
(n=8), P60–69 (n=46), P70–79 (n=22), P80–89 (n=13), P90–119 (n=20), P120–149 (n=52) 
and ≥P150 (n=40) Alb-Cre+/−;Rbpjf/f;Hnf6f/f and P20–29 (n=5), P30–39 (n=24), P40–49 
(n=19), P50–59 (n=7), P60–69 (n=27), P70–79 (n=10), P80–89 (n=11), P90–119 (n=10), 
P120–149 (n=41) and ≥P150 (n=25) Rbpjf/f;Hnf6f/f mice. 2-sided Welch’s t-test; 
**P=0.0011 at P20–29, ****P=1.7E-13 at P30–39, ****P=8.2E-12 at P40–49, 
***P=0.00019 at P50–59, ****P=8.4E-10 at P60–69, ***P=0.00055 at P70–79, nsP=0.090 
at P80–89, nsP=0.050 at P90–119, nsP=0.052 at P120–149 and nsP=0.064 at ≥P150. b, Serial 
measurements of serum total bilirubin levels in Alb-Cre+/−;Rbpjf/f;Hnf6f/f (n=14) and 
Rbpjf/f;Hnf6f/f (n=5) mice. 2-sided Welch’s t-test; nsP=0.11. c-e, Serum ALP, ALT and AST 
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levels in P43–45 (n=13), P69–82 (n=13), P120 (n=14) and P150 (n=11) Alb-Cre
+/−;Rbpjf/f;Hnf6f/f and P43–45 (n=5), P69–82 (n=4), P120 (n=9) and P150 (n=6) 
Rbpjf/f;Hnf6f/f mice. 2-way ANOVA followed by Holm-Sidak multiple comparison test; 
****P=0.000058 at P43–45, ****P=0.000019 at P69–82, **P=0.0064 at P120, nsP=0.22 at 
P150 and ***P=0.00010 at P120 vs. P69–82 (c); **P=0.0050 at P43–45, nsP=0.47 at P69–
82, nsP=0.30 at P120 and nsP=0.47 at P150 (d); **P=0.0024 at P43–45, *P=0.015 at P69–
82, ****P=0.000073 at P120 and nsP=0.061 at P150 (e). f, Sirius-red staining in P15 (n=9), 
P70–90 (n=7) and P120 (n=6) Alb-Cre+/−;Rbpjf/f;Hnf6f/f and P15 (n=5), P70–90 (n=3) and 
P120 (n=3) Rbpjf/f;Hnf6f/f mice with quantification. 2-way ANOVA followed by Holm-
Sidak multiple comparison test; nsP=0.94 at P15, ****P=0.000095 at P70–90, **P=0.0074 
at P120 and *P=0.027 at P120 vs. P70–90. g, Immunohistochemistry and Sirius-red staining 
in P313 Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice with persistent or resolved cholestasis (n=1 each). 
Measure of center is mean (a-f). Scale bars, 100 μm.
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Extended Data Figure 4: Isolation and gene expression profiling of hepatocyte-derived 
peripheral cholangiocytes.
a, FACS gates for peripheral cholangiocyte (pC, EPCAM+DBA–) and hilar cholangiocyte 
(hC, EPCAM+DBA+) isolation from Alb-Cre+/−;Rbpjf/f;Hnf6f/f and Rbpjf/f;Hnf6f/f mice. b, 
qPCR analysis of Rbpj floxed genomic DNA in hepatocyte-derived pC (HpC) and hC 
isolated from Alb-Cre+/−;Rbpjf/f;Hnf6f/f mice relative to hepatocytes isolated from 
Rbpjf/f;Hnf6f/f mice (dashed line, n=3 each). Data were normalized to a downstream 
genomic region of Rbpj to control for gene copy number. Measure of center is mean ± SEM. 
c, d, RNA-seq analysis of normal pC (n=3 mice), HpC (n=4 mice) and RBPJ- and HNF6-
deficient hepatocytes (H, n=3 mice). Heatmap of genes reflecting deletion of Rbpj and Hnf6 
(Onecut1) (c). Rbpj mRNA is present in this knockout mouse as a truncated transcript that 
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does not produce a functional protein26. Heatmap of all differentially expressed CYP genes 
distinguishing genes associated with mature (M), adolescent (A) and immature (I) 
hepatocyte differentiation or low expression in the liver (L)29 (d). 1-way ANOVA, FDR-
corrected P<0.05; fold change > 3 (c, d, except Rbpj and Notch1–4). 2-sided Student’s t-
test; bold genes P<0.05 for HpC vs. pC (c, d).
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Extended Data Figure 5: Proliferation in HpBDs and reactive ductules.
a, Size distribution of wsCK-positive DBA-positive hilar cholangiocyte clones in P90 Alb-
Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− (n=2) and Alb-Cre+/−;R26R-Confetti+/− (n=2) 
mouse livers. 2-sided Student’s t-test; **P=0.0079 for 3 cells and ***P=0.00092 for 7 cells. 
b, IF of reactive ductules in hepatocyte-fate-traced P32 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ 
mouse liver (n=3). c, Size distribution of wsCK-positive DBA-negative peripheral 
cholangiocyte clones in P90 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− (n=2) and Alb-Cre
+/−;R26R-Confetti+/− (n=2) mouse livers. 2-sided Student’s t-test; *P=0.032 for 1 cell, 
*P=0.024 for 2 cells, *P=0.020 for 3 cells and *P=0.014 for 4 cells. d, IF and breakdown of 
OPN-positive KI67-positive cells based on CK19 expression in P54 Alb-Cre
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+/−;Rbpjf/f;Hnf6f/f mouse liver (n=4). Arrowheads indicate OPN-positive KI67-positive 
CK19-negative cells. e, IF of liver of >P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f and Rbpjf/f;Hnf6f/f 
mice after DDC diet feeding for 2 (n=1 each), 4 (n=3 each) and 6 (n=1 each) weeks (wks). f, 
IF of liver and breakdown of OPN-positive cells based on hepatocyte fate tracing in >P120 
Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ (n=4) and Rbpjf/f;Hnf6f/f;R26ZG+/+ (n=3) mice fed 
DDC diet for 5 weeks starting 1 week after hepatocyte fate tracing was induced. Measure of 
center is mean (a, c, d, f) ± SEM (d, f). Scale bars, 100 μm (b, e, f), 50 μm (d).
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Extended Data Figure 6: TGFβ signaling in hepatocyte transdifferentiation.
a, Ink visualization of biliary tree of P32 Alb-Cre+/−;Tgfbr2f/f mouse (n=2). b, IF of P60 
Alb-Cre+/−;Rbpjf/f;Hnf6f/f and Rbpjf/f;Hnf6f/f mouse livers (n=2 each). Arrowheads indicate 
pSMAD3-positive HNF1-positive nuclei. c, Western blot with quantification of pSMAD3 in 
nuclear extracts from Alb-Cre+/−;Rbpjf/f;Hnf6f/f, Rbpjf/f;Hnf6f/f and Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f mouse livers (n=2 each). Source data are shown in 
Supplementary Fig. 1. d-f, Experimental design (d) and results of analysis of the effect of 
TGFβ signaling on biliary differentiation of adult RBPJ- and HNF6-deficient hepatocytes in 
3D culture. Phase-contrast images of RPBJ- and HNF6-deficient hepatocyte spheroids 
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embedded in collagen gels and cultured in the presence or absence of the TGFβ inhibitor 
SB-431542 (SB) for the indicated number of days (d) (e). Relative expression levels of 
cholangiocyte and hepatocyte genes in freshly isolated hepatocytes and spheroids before and 
after embedding in collagen gels (f). Gene expression in the liver of a mouse fed choline-
deficient ethionine-supplemented (CDE) diet was used as a positive control. Data are from 3 
independent cultures per treatment in a representative experiment (n=2). 2-sided Welch’s t-
test; *P=0.038 for Sox9 5 d, *P=0.044 for Sox9 10 d, **P=0.0034 for Krt19 5 d and 
**P=0.0071 for Spp1 5 d. g, Serum total bilirubin levels in P34–53 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=16) and Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=7) mice. 2-sided Welch’s 
t-test; ****P=0.000024. h, Quantification of Sirius-red staining in P58–100 Rbpjf/f;Hnf6f/f 
mice after intravenous injection of AAV8-Ef1α-caTgfbr1 at P20 (n=4). Gray area represents 
the range of liver collagen in the indicated Rbpjf/f;Hnf6f/f mice from Extended Data Fig. 3f. 
Measure of center is mean (c, f, g, h) ± SEM (f). Scale bars, 2 mm (a), 100 μm (e), 50 μm 
(b), 10 μm (b, inset).
Extended Data Table 1:
Characterization of human subjects and samples.
Human subject Gender ALGS genotype ALGS phenotype Age at 
liver 
analysis
Liver samples
ALGS patient Male Heterozygous 
JAG1 exon 1–26 
deletion
Neonatal cholestasis, 
bile duct paucity, liver 
fibrosis, portal 
hypertension, 
hepatocellular 
carcinoma, liver 
transplantation; left 
pulmonary artery 
stenosis; butterfly 
vertebrae; facial 
features
3 years Regenerative nodule 
and nonregenerated 
tissue (segment 5 of 
right lobe and segment 
8 of right lobe of 
explanted liver, 
respectively)
ALGS patient Male Heterozygous 
JAG1 exon 4 
mutation (c.
499T>A; 
p.W167R)
Failure to thrive; 
hepatomegaly, bile 
duct paucity, 
cholestasis, liver 
fibrosis; left 
pulmonary artery 
stenosis; facial features
15 years Regenerative nodule 
and nonregenerated 
tissue (biopsies of 
segment 3 of left liver 
lobe and segment 5 of 
right liver lobe, 
respectively)
Normal control Male Normal JAG1 and 
N0TCH2 sequences
None 35 years Histologically normal 
tissue (resection of 
segment 4 of left liver 
lobe for metastasis of 
rectal adenocarcinoma)
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Figure 1: Hepatocytes can convert into peripheral cholangiocytes and form pBDs contiguous 
with preexisting hBDs.
a, De novo pBD formation and hepatocyte fate tracing in Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG
+/+
 mice. Cells identified by dolichos biflorus agglutinin (DBA) lectin labeling and wide-
spectrum (ws) cytokeratin (CK) and GFP immunofluorescence (IF). b, IF of hepatocyte-fate-
traced P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mouse liver (n=7). c, Biliary tree 
visualized by retrograde ink injection into the common bile duct of P30 (n=6), P120-P138 
(n=6) and ≥P334 (n=6) Alb-Cre+/−;Rbpjf/f;Hnf6f/f and P30 (n=3) and P120-P138 (n=5) 
Rbpjf/f;Hnf6f/f mice. d, Maximum projection (top) and 3D reconstruction (bottom) of z-
stack image of hepatocyte-fate-traced P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mouse 
liver (n=2). e, IF and brightfield of hepatocyte-fate-traced P468 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mouse liver after retrograde ink injection into the common bile 
duct (≥P334, n=3). Scale bars, 2 mm (c, P30, P395 left), 500 μm (c, P138 left), 250 μm (c, 
P138 right), 100 μm (b, c, P395 right, d, e, left), 25 μm (e, middle).
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Figure 2: Hepatocyte-derived peripheral cholangiocytes are equivalent to normal mature 
peripheral cholangiocytes.
a-c, IF of hepatocyte-fate-traced P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mouse liver 
(n=3 each). Scale bars, 100 μm (c), 20 μm (a, b). d-g, RNA-seq analysis of normal 
peripheral cholangiocytes (pC, n=3 mice), hepatocyte-derived peripheral cholangiocytes 
(HpC, n=4 mice) and RBPJ- and HNF6-deficient hepatocytes (H, n=3 mice). Principal-
component analysis (d). Venn diagram showing number of genes significantly differentially 
up- and down-regulated in pC or HpC vs. H (e). Heatmaps of genes reflecting cholangiocyte 
differentiation, including genes lacking in DDC diet-induced hepatocyte-derived metaplastic 
biliary cells (top) and other marker genes (bottom) (f). Heatmaps of genes reflecting 
hepatocyte differentiation, including all differentially expressed CYP genes enriched in adult 
mouse liver (top) and other marker genes (bottom) (g). 1-way ANOVA, FDR-corrected 
P<0.05; fold change > 3 (e-g). 2-sided Student’s t-test; bold genes P<0.05 for HpC vs. pC (f, 
g).
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Figure 3: HpBD formation entails little proliferation and is driven by TGFβ signaling.
a, Possible outcomes, maximum projection image and size distribution of clones in 
hepatocyte-fate-traced P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;R26ZG+/+ mice (n=3). b, Possible 
outcomes, image stack volume projection and size distribution of clones in P150 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f;R26R-Confetti+/− (n=4) and Alb-Cre+/−;R26R-Confetti+/− (n=3) mice. c, 
Ink visualization of biliary tree of >P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=16), 
Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=4) and Alb-Cre+/−;Rbpjf/f;Hnf6f/f (n=1) mice. d, Sirius-red 
staining with quantification in >P120 Alb-Cre+/−;Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=4), 
Rbpjf/f;Hnf6f/f;Tgfbr2f/f (n=2) and Alb-Cre+/−;Rbpjf/f;Hnf6f/f (n=2) mice. Dotted lines 
represent the means of the indicated P120 mice from Extended Data Fig. 3f. e, f, Ink 
visualization of biliary tree and Sirius-red staining with quantification in P100 Alb-Cre
+/−;Rbpjf/f;Hnf6f/f mice that did (n=9) or did not (n=8) receive AAV8-Ef1α-caTgfbr1. 2-
sided Student’s t-test; *P=0.045. g, Serum total bilirubin in P36 Alb-Cre+/−;Rbpjf/f;Hnf6f/f 
mice that did (n=6) or did not (n=8) receive AAV8-Ef1α-caTgfbr1. 2-sided Welch’s t-test; 
*P=0.047. Measure of center is mean (a, b, d, f, g). Scale bars, 2 mm (c), 500 μm (e), 100 
μm (d, f), 50 μm (a), 20 μm (b).
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Figure 4: Clinical relevance and therapeutic potential of HpBD formation.
a, Experimental design for hepatocyte transplantation. b, IF of P127 mouse (n=5) 
transplanted with adult GFP-expressing RBPJ- and HNF6-deficient hepatocytes. c, IF of 
P152 mouse (n=4) transplanted with adult RFP-expressing hepatocytes. d, IF of liver of P72 
mouse (n=2) transplanted at P43 with hepatocytes isolated from P287 Alb-Cre+/−;R26R-
ZsGreen+/+ mouse. e, f, Immunohistochemistry and IF of ALGS (n=2) and normal (n=1) 
human livers. Arrowheads indicate nuclear pSMAD3 in pBDs. Scale bars, 100 μm (b, c, e, 
f), 50 μm (d).
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